Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hepatic Encephalopathy × phenylacetic acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1 Lymphoma, Follicular 1 Hepatic Encephalopathy 1 Familial ependymoma 1 Central Nervous System Neoplasms 1 Astrocytoma 1

Interventions

phenylacetic acid 1 ammonul 1 Sodium Benzoate 1 Glucose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00597909 2024-12-17

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Amgen

Phase 2 Terminated

Hepatic Encephalopathy, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡